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Summary
Introduction: Epilepsy associated with tuberous sclerosis complex (TSC) is drug
resistant in more than half of the patients. Epilepsy surgery may be an alternative
treatment option, if the epileptogenic tuber can be identified reliably and if seizure
reduction is not at the expense of cognitive or other functions. We report the pre-
surgical identification of the epileptogenic tuber and post-surgical outcome of
patients with TSC in The Netherlands.
Methods: Twenty-five patients underwent the pre-surgical evaluation of the Dutch
Comprehensive Epilepsy Surgery Programme, including a detailed seizure history,
interictal and ictal video EEG registrations, 3D FLAIR MRI scans and neuropsychological
testing. Suitability of the candidates was decided in consensus. Seizure outcome,
scored with the Engel classification, and cognition were reassessed at fixed post-
surgery intervals.
Results: Epilepsy surgerywas performed in six patients. At follow-up, four patients had
Engel classification 1, two had classification 4. Improved development and behaviour
was perceived by the parents of two patients. Epilepsy surgery was not performed in 19
patients because seizures were not captured, ictal onset zones could not be localised or
were multiple, interictal EEG, video EEG and MEG results were not concordant, or* Corresponding author at: Department of Neurology, C03236, University Medical Centre, P.O. Box 85500, 3508 GA Utrecht, The
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seizure burden had diminished during decision making. A higher cognition index was
found in the surgical patients compared to the non-surgical candidates.
Conclusions: Epilepsy surgery can be performed safely and successfully in patients in
whom semiology, interictal EEG, ictal EEG, MEG and the location of tubers are
concordant. In other cases the risk of surgery should be weighed against the chance
of seizure relief and in case of children subsequent impact on neurodevelopment.
# 2007 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.Introduction
Cortical tubers, the hallmark of tuberous sclerosis
complex (TSC) are associated with a variety of
neurological symptoms including epilepsy and men-
tal retardation. Epilepsy is often the presenting
symptom and seizures occur in the majority of
patients.1 The manifestation of epilepsy is age-
related, with the highest incidence in the first year
of life. In children with infantile spasms (IS) TSC
accounts for 10—30% of cases. Focal seizures are the
main seizure type in older patients with TSC, but
these can also occur in children with TSC-related IS.
Only few studies have reported long term follow up
in TSC.2—5 Although a good short-term outcome has
been described, relapses are frequent and long-
term outcome is unfavourable with respect to the
severity of epilepsy and mental status.6
Adequate treatment of the seizures is mandatory.
Despite ongoing development of new anti-epileptic
drugs, epilepsy in TSC is often medically intract-
able.7 Other treatment options are the ketogenic
diet, vagal nerve stimulation and epilepsy surgery.
Successful epilepsy surgery in patients with TSC
was published for the first time in 1964.8 Subse-
quently, many authors have reported good seizure
outcome after epilepsy surgery in series of selected
patients with TSC.9—20 We performed a systematic
review of the published cases from observational
studies regarding epilepsy surgery in patients with
TSC. Studies were included if they at least reported
quantitative seizure outcome and description of the
type of surgery. Seizure freedom was achieved in
101 of the 177 patients (57%) and seizure frequency
reduced by >90% in another 32 patients (18%) (total
of good seizure outcome in 75% of patients).21
Source localisation and advanced neuro-imaging
techniques have improved the demarcation of the
epileptogenic zone and its relation to tubers
enabling epilepsy surgery in an increasing number
of patients with TSC.
We report on pre-operative identification of the
epileptogenic tuber in patients with TSC and drug
resistant epilepsy, on surgical removal of the pre-
sumed epileptogenic tuber and on outcome of this
treatment in terms of both seizure frequency and
cognitive function.Methods
Between 1999 and 2006, 25 patients diagnosed with
TSC according to revised diagnostic criteria,22 in 21
patients confirmed by DNA analyses (10 TSC1 and 11
TSC2), were examined at the outpatient depart-
ment of Paediatric Neurology (Sylvia To`th Centre)
and Neurology, UMC, Utrecht, The Netherlands, and
referred for pre-operative work-up to the Dutch
Comprehensive Epilepsy Surgery Programme.
Pre-operative evaluation included: detailed (sei-
zure) history and physical examination, cerebral MRI
scans, high resolution (HR) EEG, seizure recording
with long-term video EEG, and a comprehensive
neuropsychological assessment. Additionally, mag-
neto-encephalography (MEG) recording was per-
formed if cooperation was expected. When
appropriate a Wada test, for evaluation of language
and memory networks, was performed at a second
stage.
MR images were processed on a Philips Gyroscan
ACS-NT 1.5 T whole body system (Philips Medical
Systems, Best, The Netherlands). All patients under-
went a transaxial or coronal Fluid Attenuated Inver-
sion Recovery (FLAIR) and a transaxial T1 scan. Slice
thickness was 1.5 mm. without interslice gap. Scan
parameters were: repetition time (TR), 11,000 ms;
echo time (TE), 125 ms; inversion time (TI),
2600 ms. Tubers were automatically segmented
with use of a KNN segmentation technique.23,24
HR EEG recording (85 channel; BioSemi Mark-6,
Brainstar system 4.0) was performed at a sampling
rate of 1024 Hz, using a cap containing Sn electro-
des (ElectroCap Inc.). The electrodes of the HR
EEGs were positioned according to the 10% system
accepted by the American EEG society. Electrode
positions were registered using a magnetic track-
ing device (Polhemus, Colchester, VT, USA). In
addition, three anatomical marker points (e.g.
nasal and pre-auricular) and head-shape were
measured, which allowed matching with MRI and
MEG markers.
Video EEG was planned in all with 21-channel
recordings with electrode positions according to
the 10—20 system. Registration of at least two
seizures from each seizure type was required for
continuation of the pre-surgical programme.
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fixed battery according to the widely varying age
and abilities of the patients. Every patient under-
went at least a test of intelligence or of mental
development.25 The other tests covered major
domains of cognition, i.e. intelligence, vocabulary,
memory and learning, graphical construction,
executive functioning, attention, speed and fine
motor functions. The following tests were per-
formed: Dutch versions of Wechsler Adult Intelli-
gence Test, Wechsler Intelligence Scales for
Children-Revised or Wechsler Preschool and Primary
Scales of Intelligence, Wechsler Memory Scale,
Visual Retention Test, California Verbal Learning
Test, Controlled Oral Word Production, Wisconsin
modified Card Sorting Test, Trail Making Parts A and
B, Reaction times, and Manual tapping.26 Adminis-
tration and scoring were according to the test man-
uals. The results (quotient scores, centiles or
standard scores) were converted to a general scale
with the values 1 (extremely below average), 2
(below average), 3 (average) and 4 (above average).
In case of cut-off scores, scale values 1 and 3 were
used. We assigned a ‘cognition index’ to each
patient by adding her/his scale values and dividing
the sum by her/his number of tests (maximum of
10). When calculating the cognition index from the
scaled values, differences in the number of tests
used to assess the domains were allowed for by
granting a factor 3 to intelligence scores and a
factor 0.5 to both California Verbal Learning Test
scores. The cognition index could vary between 1.00
and 4.00.
MEG, using 151 axial gradiometers arranged as a
helmet (Omega 151, CTF system Inc., Port Coqui-
tlam, British Columbia, Canada), were recorded at a
sampling rate of 625 Hz, inside a magnetically
shielded chamber (Vacuumschmelze GmbH, Hanau,
Germany). Head position with respect to the helmet
and, after each recording session, electrode posi-
tions and head-shape were recorded, using four
magnetic localising coils. The signals were (soft-
ware) bandpass filtered between 0.7 and 70 Hz.
When performing the Wada test, effectiveness of
the amobarbital injection was EEG-controlled. Lan-
guage processing was screened by asking the patient
to name five visually presented everyday objects
such as spoon and toothbrush, to describe the ‘Coo-
kie theft’ Picture27 and to execute four items from
the ‘Token test’.28 Results were qualitatively
judged. With respect to memory screening, the
patient was asked to look at a picture of a everyday
subject, a photograph of a person, a playing card, a
card with the name of a country, and a card with a
Dutch saying for recall 15 min later. A passing score
of 60% recall was required.Results of the above mentioned investigations
were evaluated in the Dutch Collaborative Epilepsy
Surgery Programme. Patients in whom seizure semi-
ology, interictal EEG recording, localisation of the
ictal onset zone, and localisation of the target tuber
were concordant were considered eligible for epi-
lepsy surgery. Image guided surgery was performed
using Stealth Station (Medtronic). With the results of
the video EEG recording and if available the MEG
results, the target tuber was identified. This epi-
leptogenic tuber was demarcated on T2 weighted
images. Electrocorticography (ECoG) tailored the
resection.
Outcome was evaluated with neurological exam-
ination at 3, 6 and 12 months and at the end of
follow-up (most recent visit to outpatient clinic). A
postoperative MRI was performed at 3 months and
neuropsychological examinations followed at 6, 12
and 24 months. Post-operative seizure outcome was
scored using the Engel classification.29Results
Table 1 summarizes demographic and pre-surgical
illness variables of the 25 TSC patients.
Seizure semiology
Median age at seizure onset was 0.6 years, range
0.1—14 years. At onset 14 patients had infantile
spasms (IS), 6 had complex partial seizures (CPS),
4 had secondary generalised tonic clonic seizures
(sGTCS), and 1 had tonic seizures (TS). At time of
examination 19 patients had CPS (the sole seizure
type in 12), 7 had TS (the sole type in 2), 6 had sGTCS
(the sole type in 2), 2 had myoclonic seizures (MS)
and 1 patient had atonic seizures. Seizure frequency
was daily in 13 patients, weekly in 9 patients and
less frequent in 3 patients.
MRI scans
Multiple tubers were found in all patients. The med-
ian number of tubers (assessed in 22 patients) was 27,
range 8—58. Median tuber/brain volume ratio (cal-
culated by dividing total tuber volume by total brain
volume, excluding CSF) was 1.2, range 0.2—5.1%.
Interictal EEG
In one patient interictal epileptiform activity was
absent. The interictal epileptiform activity could be
localised to one region in seven patients and was
multifocal in the other 17, involving both hemi-
spheres in 13 patients.
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Table 1 Presurgical evaluation of 25 patients with tuberous sclerosis and drug resistant epilepsy
Patient/age
(years)
Age at at
onset (years)
Seizure type
at onset
Semiology Seizure
frequency
CI Interictal EEG Ictal EEG Tubers no/
volume ratio
MEG
1/19 0.6 IS sGTCS Weekly 2.3 R posterior temporal,
L frontotemporal
L frontotemporal 18/0.34 R parieto
temporal
2/10 1.2 TS TS, CPS Daily 1.0 R parietal, R temporal,
L temporal
No seizures 20/0.18
3/10 0.9 sGTCS CPS Weekly 2.0 R hemisphere, L
posterior temporal
Multiple onset zones 20/1 Few spikes
4/27 9 sGTCS CPS Weekly 3.4 L frontotemporal L mesiotemporal 53/1.0 Few spikes
5/4 0.1 CPS, TS TS Daily 1.0 R frontocentral, L
frontocentral, L temporal
L central 29/2.52
6/24 0.6 IS sGTCS, CPS Daily 2.0 L hemisphere, R frontopolar L central 24/1.49
7/17 5 CPS CPS Weekly 3.8 R and L ant. temporal,
R posterior temporal
R temporal 19/0.34 R temporal
8/3 0.2 IS TS, MS, CPS Daily 1.0 Multifocal, R frontotemporal R frontotemporal 27/1.69
9/22 0.8 IS sGTCS Monthly 1.4 L temporal, R frontoparietal No seizures 35/1.24 Few spikes
10/2.3 0.5 IS CPS Daily 1.0 L posterior temporal,
L and R parietal
No seizures 29/2.69
11/30 0.4 IS CPS Monthly 1.9 L centroparietal Not performed 58/1.68 Few spikes
12/10 0.1 IS TS, aTS, CPS, MS Daily 1.0 R hemisphere, L parietal Not localising
13/5 0.4 IS CPS Daily 1.0 L frontopolar/temporal,
R anterior temporal
Not localising 32/1.48
14/5 0.2 IS CPS Daily 1.0 L parieto-occipital L parietal 8/0.17
15/3.5 0.5 CPS CPS with
myoclonias
Daily 2.0 R parieto-occipital R temporo-occipital 17/0.19
16/9 0.3 IS CPS Monthly 1.0 L parietal, L temporal No seizures 34/5.14
17/3 0.2 IS TS Daily 1.0 R hemisphere Not localising 20/0.32
18/23 12 sGTCS CPS Daily 3.0 R frontopolar R frontopolar 5 R frontal/
frontopolar
19/5 2.3 CPS CPS Weekly 1.8 R posterior temporal R posterior
temporal
26/0.52 R posterior
temporal
20/22 0.3 IS CPS, sGTCS Daily 1.0 No epileptiform activity Not localising 24/1.49
21/28 14 sGTCS sGTCS, TS, CPS Weekly L frontocentral Not localising L frontal
22/36 0.9 CPS CPS Weekly 2.4 R frontotemporal R mesiotemporal 34/1.84 R frontotemporal
23/34 0.8 IS CPS, sGTCS Weekly 1.2 R and L temporal,
parasaggital
Multiple onset zones 30/1.08 L parietal
24/9 0.3 IS CPS, MS Daily 1.0 R hemisphere, L temporal L centroparietal 18/0.32
25/3 1.5 CPS CPS Weekly 3.0 R central, L temporal No seizures 10/0.18
CI: cognition index, MEG: magneto-encephalography, IS: infantile spasms, sGTCS: secondary generalised tonic clonic seizures, CPS: complex partial seizures, TS: tonic seizures, MS: myoclonic
seizures, aTS: atonic seizures, R: right, L: left, ant.: anterior.
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One patient feared the surgical procedure and dis-
continued the pre-surgical programme before ictal
registration. In nine patients, one region of seizure
origin was found. Seizures were not captured in five
patients. Multiple regions of seizure onset were
found in two patients. Seizure origin was diffuse
in five patients and multifocal in three patients.
Cognition index was calculated in 24 patients.
The cognition index was above average in only one
patient, average in three, below average in six and
extremely below average in 13 patients. Cognition
was not assessed in one patient.
MEG was performed in 11 patients. In four
patients too few spikes were identified and source
localisation could not be applied. Unifocal epilepti-
form activity was seen in six patients. Results were
concordant with interictal EEG activity in five of
these patients, identifying the target tuber.
A Wada test was performed bilaterally in two
patients with the epileptogenic tuber in the right
temporal lobe (nos. 7 and 22), because post-opera-
tive memory deficit was feared. Both showed lan-
guage representation in the left hemisphere. With
respect to memory, recall after amobarbital injec-
tion in the right carotid artery was 100% in patient 7
and 80% in patient 22, which rendered them suitable
candidates for right temporal lobe surgery.
Epilepsy surgery was not performed in 19
patients (Fig. 1), including the patient who discon-
tinued the programme and the five patients in
whom video EEG recording failed to capture sei-
zures. In two patients (patients 1 and 23) results of
interictal EEG, video EEG recording and MEG were
not concordant. In five patients the ictal onset zone
could not be localised (patients 12, 13, 17, 20 and
21). Video EEG recording revealed multiple ictal
onset zones in three patients (patients 3, 6, and 24).
Invasive recording was not expected to identify one
epileptogenic tuber because eight of these patients
hadmultiple seizure types clinically. In two patients
surgery was postponed because seizure burdenFigure 1 Scheme showing consensus decision ofdiminished after a change in medication (patients
4 and 5). Deliberations have not yet been closed for
one patient (patient 14). Six patients underwent
epilepsy surgery (Table 2). Seizure semiology had
been consistent over time in five of them, but had
changed in patient 8. Further, results of interictal,
ictal, and MEG recordings (performed in four of the
surgical patients) and the location of one or a
cluster of tubers were all concordant. Patients
for whom surgery was considered an option differed
from those for whom surgery was rejected in cogni-
tion index only (means in the surgical patients
versus those for whom surgery was rejected 2.3
versus 1.5, difference 0.8; 95% confidence interval
1.6 to 0.03).
Surgery
The identified epileptogenic tuber was localised in
the right hemisphere in all surgical candidates (in
the temporal region in four, the frontal in one and
the parieto-occipital region in one patient). All four
patients with temporal lobe epilepsy had multiple
tubers located in this area. ECoG tailored the resec-
tion, resulting in a temporal lobectomy in three
(ECoG tailored the posterior resection border) a
posterior temporal resection in one, a tuberectomy
in the right parieto-occipital region in one and a
right-sided frontal corticectomy in one patient.
Intra-operative ECoG patterns consisted of a con-
tinuous spiking pattern, recruiting activity, bursts of
spikes and a sporadic spiking pattern, according to
the criteria published previously.30 ECoG after
resection showed bursts of spikes in the parieto-
temporal region in patient 8 and sporadic spikes
over the precentral gyrus in patient 18.
In all patients histopathological findings indi-
cated a disorder of cortical lamination and showed
the presence of ballooning cells in the surrounding
white matter, consistent with the diagnosis of tuber-
ous sclerosis. In patient 18 an asymptomatic giant
cell astrocytoma was present as well and was partly
resected.25 TSC patients evaluated for epilepsy surgery.
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Table 2 Results of epilepsy surgery in patients with tuberous sclerosis
Patient Age at surgery (y) EcoG Surgery PA Outcome f-u (m)
7 17 pre: continuous spiking pattern R;
midtemporal neocortex and hippocampus;
post: no epileptiform activity
R temporal lobectomy;
R amydalahippocampectomy
BC, DN Engel 1a; CI: 3.8 43
8 3 pre: continuous spiking pattern
R anterior temporal; burst and
recruiting pattern posterior temporal;
post: burst and continuous spikes
posterior temporal
R temporal lobectomy;
R amydalahippocampectomy
BC Engel 4; CI: 1.0 34
15 5 pre: continues spiking pattern over
tuber region; post: few isolated spikes
border resection
R parieto-occipital tuberectomy GC, BC Engel 1a; CI: 2.0 14
18 23 pre: continuous pattern R frontobasal;
burst of spikes subfrontal; post:
sporadic spikes R precentral
R frontopolar resection Engel 4
24 pre: continuous spiking pattern border
resection; extensive region of sporadic
spikes R frontal; post: sporadic
spikes R precentral
R frontalcorticectomy GC, BC Engel 4; CI: 3.0 37
19 5 pre: recruiting pattern R parieto-temporal;
post: sporadic spikes border resection
R posterior temporal resection DN, BC Engel 1a; CI: 2.0 76
22 36 pre: sporadic spikes R anterior temporaland
hippocampus; post: sporadic spikes border
resection
R temporal lobectomy;
R amygdalohippocampectomy
BC, MTS Engel 1b 15
ECoG: Electrocorticography, PA: Histopathology, f-u: Follow-up, y: Years, m:months, R: right, pre: pre-resection, post: post-resection, BC: ballooning cells, DN: dysmorphic neurons, GC: giant
cells, MTS: mesial temporal sclerosis, CI: cognition index.
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1 was achieved in four patients (67%, of whom three
patients had Engel 1a). One of the seizure free
patients has been taken off medication after two
years seizure freedom. The period of follow up is
relatively short in two patients who are still on anti-
epileptic drugs. Seizure frequency improved in the
first threemonths by>50% in patient 8 but worsened
again resulting in no improvement at the end of
follow-up. A re-resection was considered, but post-
poned because no general agreement was reached
which tuber should be considered epileptogenic.
Postoperative MRI findings showed incomplete
tuber resection even after a re-resection for recur-
rent seizures in patient 18. By the re-resection no
improvement of seizure pattern was achieved. Cog-
nition index was assessed at 6, 12 and 24 months in
patients 7, 8, 18 and 19, and at 6 months only in
patients 15. Post-surgical neuropsychological exam-
ination is planned in patient 22. The measured post
operative cognition index was stable over time in all
but one patient (nr 19). In this patient, cognition
index had improved slightly at 6 months (cognition
index of 2), deteriorated at 12 months (cognition
index of 1.3) and was back at the initial level post-
surgical level at 24 months (cognition index of 2).
Parents of this patient perceived improvement of
both development and behaviour postoperative.
Parents of patient 8 perceived improved develop-
ment during the first three months (period of
improved seizure control), but an arrest was
perceived when seizure frequency was back at
the pre-surgical level.
Postoperative complications consisted of quad-
rant hemianopia in patients 7, 19 and 22.Discussion
In the last few decades, a dozen series have
reported favourable seizure outcome after epilepsy
surgery in TSC.10—12,16—19,20,31—35 Seizure outcome
in our series of patients (67% Engel class 1) is com-
parable to those reported by others.
Epilepsy surgery is often not considered when
bilateral epileptogenic zones are present or when
a progressive epileptic encephalopathy is feared.
Severemental retardation is often regarded another
contraindication for epilepsy surgery because retar-
dation is frequently associated with diffuse cerebral
dysfunction. For those reasons, and because — often
numerous — tubers are not always clearly demar-
cated and may be located in eloquent cortex, the
option of epilepsy surgery has long been refused to
patients with TSC and pharmacologically intractable
epilepsy.Insights have changed and several studies have
proven that even in thepresence ofmultiple bilateral
tubers the epileptogenic zone and one or two tuber
regions consistently coincide, especiallywhenpartial
seizures are the clinical manifestation.9,16,21,31 Our
results add that even a number of 30 tubers andmore
is no impediment for good seizure outcome, if one or
two tubers can be resected. Shifting foci are often
feared, but little evidence is available to support the
hypothesis of an epileptogenic potential of every
tuber, rather, consistent electroencephalographic
patterns are found over time.36
Experience taught that surgical outcome is best
for patients in whom semiology, EEG and MRI findings
concordantly point to a surgically accessible loca-
tion.1 The favourable outcome in the admittedly
small number of suitable patients makes every
attempt to identify the primary epileptogenic zone
worthwhile. Factors related to post-surgical recur-
rence of seizures are: tonic seizures, the presence of
multiple regions of abnormal HMPAO uptake on
SPECT imaging, a corpus callosotomy (in comparison
to resective surgery), and moderate or severe intel-
lectual disability.21 The latter is in agreement with
our observation as one of the patients with poor
seizure outcome had severe intellectual disability.
Despite the considerable variation in duration of
follow up, many studies have shown that other
tubers do not become epileptogenic after removal
of the main epileptogenic region and associated
tuber. This is in agreement with the hypothesis that
after resection of a primary focus the secondary foci
may be eliminated or silenced.37 The assumption of
a poor outcome in case of multiple seizure types
with early onset, multiple cortical tubers and multi-
focal or generalised epileptogenicity is not (yet)
empirically supported, which calls for the consid-
eration of epilepsy surgery in all TSC patients with
drug resistant epilepsy.
In complex cases, additional information may
be obtained with MEG, subtraction SPECT, [11C]
methyl-L-tryptophan ([11C] AMT) PET, or invasive
EEG recording. A single localisation of epileptiform
activity was detected more often by MEG than
EEG. In addition, MEG sources were closer to pre-
sumed epileptogenic tubers than EEG sources.39
[11C] AMT) PET has been able to distinguish
between epileptogenic and non-epileptogenic
tubers.9,16 Above all, ECoG is essential to tailor
the resection of the epileptogenic zone after the
target tuber is removed. The excision should be
extended in non-eloquent cortex if a continuous
pattern of spikes, recorded with ECoG, persists
after initial tuberectomy. Although our series of
patients is too small to draw firm conclusions,
sporadic spike activity in other regions than the
452 F.E. Jansen et al.border of the resection, and incomplete resection
of the tuberal region(s) appear to be related to
recurrent seizures. When multiple epileptogenic
tubers are identified in distant brain regions epi-
lepsy surgery has proven to be very successful
with the proposed technique of multistage sur-
gery.20 The perspective of future seizure recur-
rence should be weighed against that of a
(temporary) relief of severe epilepsy, e.g. during
a critical period of neurodevelopment. Although
parents of two children in our series evaluated
development and behaviour to have ameliorated,
psychometric follow up indicated neither catch up
nor — for that matter — decay.
In conclusion, we suggest that surgical treatment
should be considered in every TSC patient with drug
resistant epilepsy. Although seizure freedom is an
unrealistic aim in patients with severe cognitive
disability, the chance of substantial seizure reduc-
tion renders surgery a compelling option if seizure
semiology, interictal HR EEG, ictal EEG, and MRI
findings are concordant. In complex patients, with-
out clear identification of the epileptogenic tuber,
more efforts with multimodal non-invasive techni-
ques (MEG, AMT PET, subtraction SPECT) are neces-
sary and worthwhile.Acknowledgments
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